68.3 F
San Diego
Monday, Sep 26, 2022
-Advertisement-
Array

StemCutis LLC Names Lee President and CEO

StemCutis LLC, an operating company of Stemedica Cell Technologies Inc., today announced the appointment of Ike Lee as president and CEO.

In addition, former pesident of the American Academy of Dermatology Dr. Ronald Wheeland joins the company’s board of directors, where he will share his expertise to advance worldwide dermatological treatments for skin diseases using stem cell therapies.

“StemCutis is privileged to engage the talents of Drs. Ike Lee and Ronald Wheeland, who will advance efforts to develop and commercialize stem cell therapies to heal compromised skin, as well as OTC products to improve skin appearance,” said Nikolai Tankovich, StemCutis’ chairman of the board and Stemedica’s president and chief medical officer.

Lee is a a 16-year biotechnology veteran and spent four years as an Instructor at the Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital. Leveraging his research and experiences at Harvard, he founded Anterogen, a stem cell therapy company in Korea. Before joining StemCutis, he served as co-founder and CEO of Alopax Bio-Consulting. He has managed several stem cell companies in the United States, Belgium and Korea and served as president and CTO of AnC Bio, CEO of CHA Biotech and co-founder and CSO of Cardio3 S.A..

- Advertisement -

Founded in San Diego in 2014, StemCutis LLC is a global biotechnology company that develops cosmetic products and dermatology therapies.

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-